PortfoliosLab logo

Enanta Pharmaceuticals, Inc. (ENTA)

Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US29251M1062
CUSIP
29251M106

ENTAPrice Chart


Chart placeholderClick Calculate to get results

ENTAPerformance

The chart shows the growth of $10,000 invested in Enanta Pharmaceuticals, Inc. on Mar 22, 2013 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $33,498 for a total return of roughly 234.98%. All prices are adjusted for splits and dividends.


ENTA (Enanta Pharmaceuticals, Inc.)
Benchmark (S&P 500)

ENTAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD-23.04%-3.97%
1M-23.21%-0.94%
6M36.37%7.48%
1Y23.18%21.47%
5Y11.35%15.05%
10Y14.69%13.09%

ENTAMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ENTASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Enanta Pharmaceuticals, Inc. Sharpe ratio is 0.40. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


ENTA (Enanta Pharmaceuticals, Inc.)
Benchmark (S&P 500)

ENTADividends


Enanta Pharmaceuticals, Inc. doesn't pay dividends

ENTADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ENTA (Enanta Pharmaceuticals, Inc.)
Benchmark (S&P 500)

ENTAWorst Drawdowns

The table below shows the maximum drawdowns of the Enanta Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Enanta Pharmaceuticals, Inc. is 68.17%, recorded on Mar 18, 2020. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-68.17%Jul 10, 2018426Mar 18, 2020
-59.6%Dec 30, 2014398Jul 28, 2016348Dec 13, 2017746
-28.47%Dec 11, 201314Dec 31, 201323Feb 4, 201437
-24.24%Sep 23, 201332Nov 5, 201315Nov 26, 201347
-23.97%Apr 11, 201347Jun 17, 201365Sep 18, 2013112
-22.54%Mar 21, 201419Apr 16, 201443Jun 18, 201462
-20.33%Feb 7, 20183Feb 9, 201852Apr 26, 201855
-19.61%Jun 20, 201434Aug 7, 201451Oct 20, 201485
-14.27%Nov 28, 201413Dec 16, 20144Dec 22, 201417
-10.33%Feb 5, 20142Feb 6, 20144Feb 12, 20146

ENTAVolatility Chart

Current Enanta Pharmaceuticals, Inc. volatility is 70.48%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ENTA (Enanta Pharmaceuticals, Inc.)
Benchmark (S&P 500)

Portfolios with Enanta Pharmaceuticals, Inc.


Loading data...

More Tools for Enanta Pharmaceuticals, Inc.